TUCSON, Ariz., April 5, 2021 /PRNewswire/ -- More than a dozen countries worldwide temporarily stopped administering the Oxford-AstraZeneca COVID vaccine, notes the Association of American Physicians and Surgeons (AAPS), because of deaths from blood clotting disorders, with either clots or excessive bleeding. Some patients experienced the extremely rare event of clots in the veins that drain blood from the brain (venous sinus thrombosis). Most countries resumed use after a short pause, when the European Medicines Agency (EMA) said the shot isn't associated with an increase in the overall risk of developing blood clots, and the benefits of using the vaccine...